Breast conservation therapy in T4 locally advanced breast cancer: Effective local control with long-term survival

2004 ◽  
Vol 11 (S2) ◽  
pp. S75-S76
Author(s):  
J. Shen ◽  
V. Valero ◽  
T. Buchholz ◽  
S. E. Singletary ◽  
K. Hunt ◽  
...  
2014 ◽  
Vol 15 (8) ◽  
pp. 3435-3441 ◽  
Author(s):  
Simon Blechman Zeichner ◽  
Ludimila Cavalcante ◽  
Gabriel Pius Suciu ◽  
Ana Lourdes Ruiz ◽  
Alicia Hirzel ◽  
...  

2015 ◽  
Vol 11 (1) ◽  
pp. 36
Author(s):  
Zorica I Tomasevic ◽  
Zoran M Tomasevic ◽  
Zeljko Kovac ◽  
Zorka Milovanovic ◽  
Dana Grujicic ◽  
...  

We present a patient who first developed a distant metastatic site in the cerebellum during treatment for Her2 3+ locally advanced breast cancer (LABC). LABC was in complete remission at that time and isolated cerebellar metastasis was resected. The patient is still alive more than 135 months after LABC diagnosis, and more than 99 months after neurosurgery, and is still receiving trastuzumab without further progression or any toxicity. To the best of our knowledge, this is first report of such exceptional disease course for a patient with a predicted grave prognosis according to all prognostic parameters.


Sign in / Sign up

Export Citation Format

Share Document